MITCHELL B OHARA

Allopathic & Osteopathic Physicians|Internal Medicine|Interventional Cardiology TAMPA, FL NPI 1285705004

General Payments — all program years on this page

$4,732.82

  • Category: General Payments
  • Program years: PY2018–2024
  • Record count: 192
  • As of (CMS publication): 2026-01-23

Latest program year (PY2024): $482.13 across 16 records · disputed records: 0

Financial relationships do not necessarily indicate an improper relationship; the data is open to interpretation.

How this figure is calculated
  • The total is the sum of the General Payments records CMS published for the labeled program year(s), exactly as published. Nothing is estimated, weighted, or combined across categories.
  • General Payments only. Research and Ownership/Investment are separate datasets and are never summed with these figures; amounts are kept separate per program year.
  • Featured-page threshold (a presentation gate, not a judgment): records>=3 OR total>=100 (all years).
  • Methodology & Data — sourcing, labeling, and limitations.

By nature of payment

Latest program year (PY2024) · sorted by reported total.

Nature of paymentAmountRecords
Food and Beverage $482.1316

By paying entity

Latest program year (PY2024) · sorted by reported total.

By program year

Program yearAmountRecords
2018 $895.3137
2019 $1,533.8640
2020 $447.2726
2021 $601.8335
2022 $570.5526
2023 $201.8712
2024 $482.1316

Records — PY2024 (16)

Record IDPaying entityAmountDate Nature of paymentDispute statusPublishedSource
1078879988 Actelion Pharmaceuticals US, Inc. $22.36 05/20/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1087271863 Novartis Pharmaceuticals Corporation $19.34 08/27/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1096906767 Novo Nordisk Inc $22.76 03/04/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1097332713 Novo Nordisk Inc $17.86 08/15/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1097365718 Novo Nordisk Inc $22.86 09/10/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1101851096 E.R. Squibb & Sons, L.L.C. $13.75 09/16/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1115979425 Amgen Inc. $18.04 09/19/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1124958544 Abbott Laboratories $125.00 09/28/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1125828849 Alnylam Pharmaceuticals Inc. $25.48 02/21/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1125828855 Alnylam Pharmaceuticals Inc. $29.73 03/05/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1125828889 Alnylam Pharmaceuticals Inc. $27.81 06/04/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1125828931 Alnylam Pharmaceuticals Inc. $22.16 11/11/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1131083775 PFIZER INC. $27.93 02/16/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1131669975 PFIZER INC. $22.79 06/12/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1132859737 ATRICURE, INC. $44.01 01/22/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1154861527 Kiniksa Pharmaceuticals International, plc $20.25 03/25/2024 Food and Beverage Undisputed 01/23/2026 View at CMS

Provenance & corrections

  • Dataset: CMS Open Payments — General Payments
  • Source: CMS Open Payments dataset (bulk file)
  • Publisher of source data: Centers for Medicare & Medicaid Services
  • Generated from: OP_DTL_GNRL_PGYR2024_P01232026_01102026.csv

One page per canonical provider; split Profile_IDs are merged via Associated_Covered_Recipient_Profile_ID_1/_2 from the Covered Recipient Profile Supplement.

Corrections to the substance of a record route to CMS through its review-and-dispute process; errors in how this site mirrors or displays a record route to us. Both paths are described in Methodology & Data.